(Q43232555)

English

Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III b

scientific article published in October 2010

Statements

Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III b (English)
Alfonso Sánchez-Muñoz
R Dueñas-García
A Jaén-Morago
E Carrasco
I Chacón
A M García-Tapiador
A L Ortega-Granados
E Martínez-Ortega
N Ribelles
M Fernández-Navarro
C de la Torre-Cabrera
B Dueñas
A I Rueda
J Martínez
C Ramírez Tortosa
M D Martín-Salvago
P Sánchez-Rovira
1 October 2010
432-437

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit